Login / Signup

Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B can increase body weight-Authors' reply.

Eiichi Ogawa
Published in: Alimentary pharmacology & therapeutics (2024)
Keyphrases
  • body weight
  • hepatitis b virus
  • antiretroviral therapy
  • liver fibrosis